Abbreviations: N/A: Not available, RCTs: Randomized controlled trials Mild GI adverse events All ten semaglutide RCTs [23 106 participants (n=12 427 in the intervention group and 10 679 in the control group)], as well as the three tirzepatide studies, [n=3788 participants (2518 in the intervention group and 1270 in the control group)], reported on overall GI adverse events at the end of follow-up
You can talk with a healthcare professional, such as a Midi clinician, who may recommend HRT or testosterone therapy, diet changes, exercise, supplements, prescription medications for pain, or alternative therapies
Take either or both
The most common is the 42 amino-acid long A42
Its important to understand that while early weight loss can be encouraging, the rate of progress may slow over time
Always follow recommended dosages and consult your healthcare provider